ǰÑÔ
ÄêËêÏà¹ØÐԻư߱äÐÔ(age related macular degeneralion, AMD)ÊÇ65ËêÒÔÉÏÍíÄêÈËÖÂäµÄÖ÷ÒªÔµ¹ÊÔÓÉ¡£AMD·ÖΪÎÞÐÂÉúѪ¹ÜÌìÉúµÄ¸ÉÐÔÒÔ¼°ÐÂÉúѪ¹ÜÌìÉúµÄʪÐÔÌåÏÖ¡£ÊªÐÔAMD»¼Õß±¬·¢CNVÊǵ¼ÖÂÊÓÁ¦ËðʧµÄ×î³£¼ûÒòËØ¡£±¾Õ½«ÏÈÈÝCNVµÄÔìÄ£ÒªÁì¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó¡¢¼ÒÍá¢â¨ºï
¡¾ÔìÄ£»úÖÆ¡¿£º
¼¤¹âÓÕµ¼CNVÄ£×ÓÊdz£¼ûµÄÒªÁì¡£1979Ä꣬RyanµÈÊ״νÓÄɸ߹¦Âʼ¤¹â´©Í¸BruchĤ֯×÷³öCNV¶¯ÎïÄ£×Ó¡£1989Ä꣬DobiÆ·¼¶Ò»´ÎÓ¦ÓÃ647nm²¨³¤¡¢120mWµÄë´¼¤¹â¿ÉÔì³ÉCNVÄ£×Ó¡£1998Ä꣬TobeµÈ½«ë´¼¤¹â¹âÄýÊõÓ¦ÓÃÓÚÖÆ×÷СÊóCNVÄ£×Ó£¬ÒԺ󼤹âÓÕµ¼CNVÄ£×Ó±»ÆÕ±éÓ¦ÓÃÓÚ»ù´¡ÊµÑéºÍÖÎÁÆÒªÁìµÄÑо¿ÖС£À¶ÂÌë²¼¤¹â´©Í¸Á¦½ÏÈõ£¬Ö÷Òª×÷ÓÃÓÚÊÓÍøÄ¤ÄÚ²ãºÍRPE²ã¡£ë´¼¤¹âÖ÷Òª×÷ÓÃÓÚRPEºÍÂöÂçĤÄڲ㡣¼¤¹âÓÕµ¼CNVÄ£×ÓµÄÓŵãÔÚÓÚÓëÈËÀàCNV¼²²¡±¬·¢×ÔÈ»Àú³ÌÏàËÆ£¬µ«²î±ðÑо¿CNVÄ£×ÓÀÖ³ÉÂʲî±ð£¬Óë²î±ðʵÑé½ÓÄɶ¯ÎïÀàÐÍ¡¢¼¤¹âÖÖÀ༰¶ÔÊÓ²ìÕï¶ÏCNVµÄ±ê×¼·×ÆçÓйء£
¡¾ÔìÄ£ÒªÁì¡¿£º
1.СÊó Ë«ÑÛµÎÓø´·½ÍÐßÁ¿¨°·µÎÑÛҺɢͫ£¬¸¹Ç»×¢Éä1£¥Îì°Í±ÈÍ×ÄÆ(10ml/kg)Âé×íСÊó£¬ÊµÑéÑÛµÎÓÃÒ½ÓÃ͸Ã÷ÖÊËáÄÆÄý½º£¬ÑÛǰ°²ÅÅ2cm×2cm¸Ç²£Æ¬£¬¾ÁÑ϶µÆÓÃ532nm¼¤¹â¹¦ÂÊ200mW£¬¹â°ßÖ±¾¶100m£¬ÆØ¹âʱ¼ä100ºÁÃ룬¾àÊÓÈéÍ·1.5-2.0PI×óÓÒλÖÃÒÔÊÓÈéͷΪÖÐÐľÙÐйâÄý£¬ÆäÖÐÐÐCNVÄ£×ÓÅжϺÍÃâÒßÓ«¹âȾɫ×éСÊó¹âÄý4~6µã£¯ÑÛ£»¹âÄýºóÓÐÆøÅݱ¬·¢±ê¼Ç»÷ÆÆBruchĤ£¬ ¼ÇΪÓÐÓõ㡣
2.¼ÒÍà ÍÃÑÛ¼¤¹âÓÕµ¼Ä£×ÓÔÚº£ÄÚÓ¦ÓýÏΪÆÕ±é£¬ÓŵãÔÚÓÚÍÃÑÛ½ÏÖ®ÊóÑÛ´ó£¬Ò×ÓÚÄ£×ÓʵÑé²Ù×÷Óë¼ì²é¡£Ë«ÑÛɢͫ£¬ÑÛ±íµÎÈëÍâòÂé×í¡£Ã¿Ö»ÑÛÔÚÈ«ÊÓÍøÄ¤¾µÏÂÓÃë´¼¤¹â£¬²¨³¤647nm£¬¹¦ÂÊ700~800mW£¬¹â°ßÖ±¾¶50µm£¬¼¤¹â¹¦ÂÊÆØ¹âʱ¼ä0.05Ã룬ÔÚÊÓÈéÍ·¼°ËèÏßÏ·½¹âÄý20¸öµã£¬¹â°ß¾àÀë300µm¡£
3.â¨ºï ºïµÄÊÓÍøÄ¤¼°»Æ°ß½á¹¹ÓëÈËÀàÏàËÆ£¬ÑÛÇò¾Þϸ±ãÓÚ²Ù×÷£¬¾ßÓÐÓ«¹âÉøÂ©µÄÌØµã£¬ÊÇÓÃÓÚÁÙ´²Ò©ÎïɸѡµÄÊ×ѡģ×Ó¡£RyanµÈʹÓÃë²¼¤¹â£¬¹¦ÂÊ200~950mW£¬¹â°ßÖ±¾¶50~200µm£¬ÆØ¹âʱ¼ä0.1~0.5Ãë¡£
¡¾Ä£×ÓÌØµã¡¿£º
1.СÊó ³£½ÓÄÉÃâÒß×黯ÊÖÒÕÓ¦ÓÃCD31±ê¼ÇÄÚÆ¤Ï¸°û£¬ÔÚ¹âÒɺó14ÌìʱCNVÄ£×ÓÊóµÄÊÓÍøÄ¤¹â¼¤²¿Î»¿É¼ûÏÔ×ŵÄÂÌɫӫ¹âÍſ飬Åú×¢ÐÂÉúѪ¹ÜÐγɣ¬´Ó¶øÌåÏÖCNVÄ£×ÓÓÕµ¼Àֳɡ£
2.¼ÒÍà ¼¤¹â°ß·ºÆðǿӫ¹âÉøÂ©ÎªCNVÐγɣ¬µÚ3~4ÖܼûÎȹ̵ÄÉøÂ©¹â°ß£¬CNV±¬·¢ÂÊ66.7£¥£¬ÉøÂ©ÂÊ51.7£¥¡£¹âÄýºó3Ìì¼´ÓÐÉÙÁ¿¹â°ß·ºÆðÓ«¹âÉøÓ¿£¬²¢Öð½¥Ôö¶à£¬21Ìì´ïá¯Á룬²¢Ò»Á¬µ½¹âÄýºó56Ìì¡£OCTÏÔʾÔìÄ£ºó7ÌìÉÙÁ¿¹â°ß²¿Î»É«ËØÉÏÆ¤²ã·´ÉäÖÐÖ¹£¬ÆäÏ·½¾ÖÔîÐÔ¸ßÃܶȺì°×É«·´ÉäÇø³ÊÍÅ¿é×´¡¢ËóÐλò²»¹æÔòÐΣ¬±ßÑØÎªñ£ºÛÐγɵIJ»¹æÔòÇ¿·´ÉäÇø£¬CNV·ºÆð£»Ö®ºóCNVÖð½¥Ôö¶à£¬ÖÁ21Ìì¸÷×é´ï×î¶à£»ÍíÆÚ²¿·ÖCNVñ£ºÛ»¯¡£Ó«¹âÉøÂ©µÄÅÌËã[£¨Ó«¹âÉøÂ©±¬·¢ÂÊ£½·ºÆðÓ«¹âÉøÂ©µÄ¼¤¹âµãÊý£¯ËùÊÓ²ìµÄ¼¤¹âµãÊý£©×100£¥]¡£
3.ºï ¹âÄýºïÊÓÍøÄ¤·ºÆðÐÂÉúѪ¹ÜÒÔ¼°ÑÛµ×Ѫ¹ÜÓ«¹âÔìÓ°ÊӲ췺ÆðѪ¹ÜÉøÂ©£¬ÎªÀֳɽ¨ÉèÁËCNV¶¯ÎïÄ£×Ó¡£µ«Ïà±ÈÊóÀàºÍ¼ÒÍ㬷ÇÈËÀàÁ鳤ÀàµÄCNVÉøÂ©ÂʽϵÍÔ¼30£¥£¬Èý¶ÈËðÉËÔ¼Õ¼70£¥£¬ËĶÈËðÉËԼΪ20£¥~40£¥¡£ÊµÑé×éӦѡÓÃ8~10Ö»ºï²Å»ª»ñµÃ¾ßÓÐͳ¼ÆÑ§ÒâÒåµÄЧ¹û¡£ÓÉÓÚºïȪԴÉÙ£¬Óöȸߣ¬ËÇÑø½ÏÄÑÌ⣬ģ×ÓÖÆ×÷Ðè4ÖÜÒÔÉÏ£¬Òò´ËÓ¦ÓÃÊÜÏÞ¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
СÊ󼤹âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊԼΪ80£¥£¬Íõ魯âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊÔ¼50£¥£¬¶øÑ¡Ó÷ÇÈËÀàÁ鳤ÀදÎD¹âÓÕµ¼CNVÄ£×ÓµÄÀÖ³ÉÂÊ×îµÍÔ¼30£¥¡£¼¤¹âÓÕµ¼CNV¶¯ÎïÄ£×Ó¿ÉÄ£ÄâÈËÀàʪÐÔAMD¼²²¡£¬½ÓÄÉÕâÖÖÒªÁìÖ±½ÓËðÉËÂöÂçĤ£¬ÓëÈËÀàCNV±£´æÅäºÏÖ®´¦£¬¹ØÓÚÑо¿ÊªÐÔAMDµÄ·¢²¡»úÖÆÓëÖÎÁÆÒªÁìÓÐÖ÷ÒªµÄÁÙ´²¼ÛÖµ¡£
²Î¿¼ÎÄÏ×£º
1.ÍõÓ¦Àû£¬»ÝÑÓÄ꣮ÌÇÄò²¡ÊÓÍøÄ¤²¡±ä»»ÎïÄ£×ÓÑ¡ÔñµÄ×¢ÖØÊÂÏÖлªÑÛ¿ÆÔÓÖ¾£¬2012,48 (7):587-590
2.Baehr W, Frederick JM. Naturally occurring animal models with outer retina phenotypes. Vis Res,2009,49: 2636-2652
3.Bourne MC, Campbell DA, Tansley K. Hereditary degeneration of rat retina. Br J Ophthalmol, 1938,22(10): 613-623
4.Bundey S,Crews SJ. A study of retinitis pigrnentosa in the city of Birmingham-I. J Med Genet, 1984,21(6):417-420
5.Chang B, Heckenlively IB,Bayley PR.et a.I. The nob2 mouse, a null mutation in Cacnalf: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci, 2006, 23 (1): 11-24
6.Criswell MH,Ciulla TA,Hill TE,et al. The squirrelmonkey: characterization of a new-world primate model of xperimental choroidal neovascularizalion and comparison with the macaque. Invest Ophthalmol Vis Sci,2004, 45 (2): 625-634
7.Gu Y, Wang L,Zhou J,et al. A naturally-occurring mutation in CacnaIf in a rat model of congenital stationary night blindness. Mo! Vis,2008, 14(1):20-28
8.Lue CL. Rod cell activity in retinal degenerative rats. J Formos Med Assoc, 1994,93(7):605-610
9.Pinkert CA. Transgenic animal technology. New York: Academic Press, 1994
10.Sato H, Suzuki T, Ikeda K, et aL A monogenic dominant mutation in Rom l generated by N-ethyl-N-nitrosourea mutagenesis causes retinal degeneration in mice. Mol Vis,2010, 16:378-391
11.Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci, 1983, 24 (3):285-287
12.Won J, Shi LY, Hicks W, et al. Mouse model resources for vision research. J Ophthalmol,2011,2011:391384
13.Xie B,Nakanishi S,Guo Q,et al. A novel middlewavelength opsin (M-opsin) null-mutation in the retinal cone dysfunction ral. Exp Eye Res,2010,91(1):26-33